Burden of Illness: A Systematic Review of Depression in Chronic Rhinosinusitis

Schlosser, Rodney J.; Gage, Selby E; Kohli, Preeti; Soler, Zachary M.

doi:10.2500/ajra.2016.30.4343

Cited by 61 publications

(88 citation statements)

References 30 publications

(110 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We estimated the prevalence of depression to be about 21% in CRS patients which is in line with other studies that used HADS questionnaire and reported the prevalence of 11-23.8% [11]. The main reason of this wide range in these studies can be related to different HADS cut-off points used by them.…”

Section: Discussionsupporting

confidence: 87%

“…In a cohort study in 2011 the incidence of depression in patients with CRS was 77% more than control group with a hazard ratio of 1.56 [8] while these studies report depression as a highly prevalent disorder in CRS patients there are some other studies which report the prevalence of highly probable depression as low as 3 to 4% [9,10]. In 2016 Schloser et al reviewed 13 studies and reported the prevalence of probable depression to be from 11 to 40% [11]. Considering this wide range of results and the fact that causality in this association is not yet understood, it seems necessary to conduct more studies in this field.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Mood Disorders among Chronic Rhino-Sinusitis Patients

Gharaati¹,

Amini²,

Abdollahi³

et al. 2017

J Psychiatry

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 87%

Section: Introductionmentioning

confidence: 99%

Mood Disorders among Chronic Rhino-Sinusitis Patients

Gharaati¹,

Amini²,

Abdollahi³

et al. 2017

J Psychiatry

View full text Add to dashboard Cite

“…Although it varied slightly depending on the method of diagnosis (i.e., physician diagnosed, PHQ, HADS, BID), the overall frequency International Archives of Otorhinolaryngology was significant, ranging from 18 to 40% of patients with CRS. 4 Given this opportunity to improve care for patients with increased risk of comorbid psychiatric illness, we sought to determine the knowledge, attitudes and practices of ARS members in the evaluation and management of MDD in patients with chronic rhinosinusitis. The ARS was chosen as a representative body of otolaryngologists who have a clinical emphasis or interest in the care of patients with rhinologic diseases.…”

Section: Discussionmentioning

confidence: 99%

Diagnosis and Management of Depression in CRS: A Knowledge, Attitudes and Practices Survey

Gill

Levy

Wilson

et al. 2020

Int Arch Otorhinolaryngol

View full text Add to dashboard Cite

Introduction Comorbid major depressive disorder (MDD) is present in up to 25% of chronic rhinosinusitis (CRS) cases and provides prognostic information for patients undergoing endoscopic sinus surgery (ESS). Clinical visits offer an opportunity to identify at-risk patients. Objective The purpose of the present study is to evaluate practice patterns among members of the American Rhinologic Society (ARS) in screening for/diagnosing MDD. Methods A 21-question survey was distributed to 1,206 members of the ARS from May 26, 2018 to June 12, 2018. The impact of demographic factors, including hospital setting, fellowship status, and experience were assessed through chi-squared analysis. Results A total of 80 members of the ARS completed the survey, yielding a response rate of 7%. Half of the respondents worked in academic settings and 43% had completed a rhinology fellowship. Twenty percent of the participants felt comfortable diagnosing or managing MDD, while only 10% of participants screened for MDD in patients with CRS. Respondents cited a lack of training (76%) and unfamiliarity with diagnostic criteria (76%) as barriers to the routine assessment of MDD. Most respondents (95%) considered comorbid psychiatric illness to negatively impact outcomes following ESS. Fellowship-trained respondents were significantly more likely to implement screening tools in their practice (p = 0.05), and believe in the negative impact of MDD on postoperative outcomes (p = 0.007), cost of care (p = 0.04) and quality of life (p = 0.047). Conclusion Amongst ARS members, 95% of the respondents consider comorbid MDD to negatively impact patient outcomes following ESS. Regardless, a large proportion of surgeons neither screen nor feel comfortable diagnosing MDD.

show abstract

“…It is unclear if this is a causative relationship; however it appears likely that co-existing depression results in both higher rates of symptom reporting and amplifies symptom severity, particularly in CRSsNP (103) . Patients with co-existing depression report poorer disease specific health related quality of life both before and after treatment for CRS (104) . Although treatment for CRS has been shown to reduce depression scores, there is no evidence on whether treatment of depression may result in improvement of CRS-related QOL.…”

Section: Management Of Individuals With Recalcitrant Crs Is Based Onmentioning

confidence: 99%